Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Non-Current Deferred Tax Liability (2021)

Historic Non-Current Deferred Tax Liability for Inmune Bio (INMB) over the last 1 years, with Q4 2021 value amounting to $257000.0.

  • Inmune Bio's Non-Current Deferred Tax Liability changed N/A to $257000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $257000.0, marking a year-over-year change of. This contributed to the annual value of $257000.0 for FY2021, which is N/A changed from last year.
  • Inmune Bio's Non-Current Deferred Tax Liability amounted to $257000.0 in Q4 2021.
  • Inmune Bio's 5-year Non-Current Deferred Tax Liability high stood at $257000.0 for Q4 2021, and its period low was $257000.0 during Q4 2021.